Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   ROBERT KRANCE   and   ERIN DOHERTY.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.486
         
        
        
     
 
    
        
        - 
            Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia? Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):171-174.
            
            
                Score: 0.877
             
- 
            Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2023 05 09; 7(9):1823-1830.
            
            
                Score: 0.211
             
- 
            Acute exacerbation of graft-versus-host disease following SARS-CoV2 infection after hematopoietic stem cell transplant in two pediatric patients. Pediatr Blood Cancer. 2022 10; 69(10):e29661.
            
            
                Score: 0.194
             
- 
            Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab. Pediatr Hematol Oncol. 2024 May; 41(4):260-272.
            
            
                Score: 0.055
             
- 
            Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 02; 30(2):217-227.
            
            
                Score: 0.054
             
- 
            Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585.
            
            
                Score: 0.048
             
- 
            Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience. Bone Marrow Transplant. 2021 11; 56(11):2797-2803.
            
            
                Score: 0.046